Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans

By Pittman P.R.   Kim-Ahn G.   Pifat D.Y.   Coonan K.   Gibbs P.   Little S.   Pace-Templeton J.G.   Myers R.   Parker G.W.   Friedlander A.M.  

Vaccine, Vol. 20, Iss. 9, 2002-01 ,pp. : 1412-1420

Elsevier

Access to resources Recommend Favorite

Monitoring anthrax vaccine safety in US military service members on active duty: surveillance of 1998 hospitalizations in temporal association with anthrax immunization

By Sato P.A.   Reed R.J.   Smith T.C.   Wang L.  

Vaccine, Vol. 20, Iss. 17, 2002-05 ,pp. : 2369-2374

Elsevier

Access to resources Recommend Favorite

Chlorpyrifos: Hazard Assessment Based on a Review of the Effects of Short-term and Long-term Exposure in Animals and Humans

By Cochran R.C.   Kishiyama J.   Aldous C.   Carr W.C.   Pfeifer K.F.  

Food and Chemical Toxicology, Vol. 33, Iss. 2, 1995-02 ,pp. : 165-172

Elsevier

Access to resources Recommend Favorite

Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience

By Pittman P.R.   Liu C.T.   Cannon T.L.   Makuch R.S.   Mangiafico J.A.   Gibbs P.H.   Peters C.J.  

Vaccine, Vol. 18, Iss. 1, 1999-08 ,pp. : 181-189

Elsevier

Access to resources Recommend Favorite

Anthrax vaccine efficacy in golden Syrian hamsters

By Fellows P.F.   Linscott M.K.   Little S.F.   Gibbs P.   Ivins B.E.  

Vaccine, Vol. 20, Iss. 9, 2002-01 ,pp. : 1421-1424

Elsevier

Access to resources Recommend Favorite